Sign In
Buy BDX
$170.66
+0.540 (+0.317%)
At Close: Aug 05, 2026
Best Dividend Aristocrats For August 2025
05:19am, Monday, 28'th Jul 2025
Dividend Aristocrats are outperforming SPY in July but still trail year-to-date; select Aristocrats delivered double-digit gains and strong dividend growth. 47 of 69 Aristocrats raised dividends in 20
22 Dividend Kings At Discounted Valuations
12:14pm, Sunday, 27'th Jul 2025
Dividend kings can offer reliable income growth and capital appreciation, making them attractive for long-term investors. During our screening today, we have 22 dividend kings trading at what could be
20 Kiplinger July Dividend Favorites: No Cigars
11:45am, Sunday, 27'th Jul 2025
Dividend stocks are regaining appeal as interest rates fall, offering higher returns and lower risk compared to non-dividend payers over the long term. Top Kiplinger dividend 'dogs' are projected to d
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
06:50am, Wednesday, 23'rd Jul 2025
FRANKLIN LAKES, N.J. , July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination prod
BD Board Declares Dividend
04:15pm, Tuesday, 22'nd Jul 2025
FRANKLIN LAKES, N.J. , July 22, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decla
Best Dividend Kings: July 2025
09:31am, Tuesday, 22'nd Jul 2025
14 Dividend Kings continue to outperform the S&P 500 in 2025. Dividend growth remains healthy, with one recent increase and a collective 2025 growth rate of 5.23%. Seventeen Dividend Kings currently a
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merg
BD Partners With Waters to Build High-Volume Diagnostics Leader
10:16am, Tuesday, 15'th Jul 2025
BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.
Becton Dickinson gets its spinoff deal, but the stock is still falling
07:48am, Monday, 14'th Jul 2025
Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
04:15pm, Monday, 07'th Jul 2025
FRANKLIN LAKES, N.J. , July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin ha
Buy 3 IDEAL Dividend Kings Of 25 'Safer' In July's 55
05:37am, Friday, 04'th Jul 2025
Most Dividend Kings are overpriced, but six currently offer fair value, with annual dividends from $1,000 invested exceeding their share prices. Top-yielding Dividend Kings like Altria, Northwest Natu
3 Undervalued Dividend King Stocks With Over 50% Upside Potential
09:47pm, Tuesday, 01'st Jul 2025
As we enter the second half of 2025, now is the perfect time to invest in dividend stocks — especially those with quality underlying fundamentals that pay high dividend yields.
Best Dividend Aristocrats For July 2025
07:19am, Sunday, 29'th Jun 2025
Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising pa
Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now
08:33am, Wednesday, 25'th Jun 2025
Shares of Becton Dickinson and Company BDX are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting until
